{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T16:51:05Z","timestamp":1791823865154,"version":"4.3.4"},"reference-count":48,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.autrev.2022.103187","type":"journal-article","created":{"date-parts":[[2022,9,7]],"date-time":"2022-09-07T23:10:53Z","timestamp":1662592253000},"page":"103187","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"title":["Autoimmune encephalitis after herpes simplex encephalitis: A still undefined condition"],"prefix":"10.1016","volume":"21","author":[{"given":"Susanna","family":"Esposito","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Autore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Argentiero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Greta","family":"Ramundo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Principi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2022.103187_bb0005","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/S1473-3099(10)70222-X","article-title":"Causes of encephalitis and differences in their clinical presentations in England: a multicentre, population-based prospective study","volume":"10","author":"Granerod","year":"2010","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.autrev.2022.103187_bb0010","first-page":"166","article-title":"Diagnosis and treatment of viral encephalitis. Postgrad Med J 2002; 78:575\u2013583 Miller S, Mateen FJ, Aksamit AJ Jr. Herpes simplex virus 2 meningitis: a retrospective cohort study","volume":"19","author":"Chaudhuri","year":"2013","journal-title":"J Neurovirol."},{"key":"10.1016\/j.autrev.2022.103187_bb0015","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s11908-017-0568-7","article-title":"Herpes simplex encephalitis: an update","volume":"19","author":"Gnann","year":"2017","journal-title":"Curr Infect Dis Rep"},{"key":"10.1016\/j.autrev.2022.103187_bb0020","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.autrev.2018.08.009","article-title":"An evolving redefinition of autoimmune encephalitis","volume":"18","author":"Esposito","year":"2019","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2022.103187_bb0025","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1007\/s10072-013-1475-9","article-title":"Herpes simplex encephalitis: clinical presentation, neurological sequelae and new prognostic factors. Ten years of experience","volume":"34","author":"Riancho","year":"2013","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.autrev.2022.103187_bb0030","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/S1474-4422(18)30244-8","article-title":"Frequency, symptoms, risk factors, and outcomes of autoimmune encephalitis after herpes simplex encephalitis: a prospective observational study and retrospective analysis","volume":"17","author":"Armangue","year":"2018","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.autrev.2022.103187_bb0035","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/S1474-4422(18)30279-5","article-title":"Autoimmune encephalitis after herpes simplex encephalitis: insights into pathogenesis","volume":"17","author":"Gelfand","year":"2018","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.autrev.2022.103187_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2022.103118","article-title":"Rare antibody-mediated and seronegative autoimmune encephalitis: an update","volume":"21","author":"Seery","year":"2022","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2022.103187_bb0045","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1212\/01.WNL.0000073985.71759.7C","article-title":"Herpes simplex encephalitis relapses in children: differentiation of two neurologic entities","volume":"61","author":"De Ti\u00e8ge","year":"2003","journal-title":"Neurology."},{"key":"10.1016\/j.autrev.2022.103187_bb0050","doi-asserted-by":"crossref","first-page":"235","DOI":"10.2176\/nmccrj.cr.2020-0180","article-title":"Relapse of herpes simplex encephalitis by epilepsy surgery 35 years after the first infection: a case report and literature review","volume":"8","author":"Iimura","year":"2021","journal-title":"NMC Case Rep J"},{"key":"10.1016\/j.autrev.2022.103187_bb0055","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1002\/ana.23689","article-title":"N-methyl-D-aspartate receptor antibodies in herpes simplex encephalitis","volume":"72","author":"Pr\u00fcss","year":"2012","journal-title":"Ann Neurol"},{"key":"10.1016\/j.autrev.2022.103187_bb0060","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1212\/CPJ.0000000000000219","article-title":"Practice current: how do you treat anti-NMDA receptor encephalitis?","volume":"6","author":"Bartolini","year":"2016","journal-title":"Neurol Clin Pract"},{"key":"10.1016\/j.autrev.2022.103187_bb0065","article-title":"Contemporary advances in anti-NMDAR antibody (ab)-mediated encephalitis","volume":"21","author":"Seery","year":"2022","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2022.103187_bb0070","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S1474-4422(12)70310-1","article-title":"Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study","volume":"12","author":"Titulaer","year":"2013","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.autrev.2022.103187_bb0075","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S1474-4422(10)70253-2","article-title":"Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis","volume":"10","author":"Dalmau","year":"2011","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.autrev.2022.103187_bb0080","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.ejpn.2017.12.014","article-title":"Initial clinical presentation of young children with N-methyl-d-aspartate receptor encephalitis","volume":"22","author":"Favier","year":"2018","journal-title":"Eur J Paediatr Neurol EJPN"},{"key":"10.1016\/j.autrev.2022.103187_bb0085","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1212\/WNL.0000000000003713","article-title":"Investigations in GABAA receptor antibody-associated encephalitis","volume":"88","author":"Spatola","year":"2017","journal-title":"Neurology."},{"key":"10.1016\/j.autrev.2022.103187_bb0090","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S1474-4422(15)00401-9","article-title":"A clinical approach to diagnosis of autoimmune encephalitis","volume":"15","author":"Graus","year":"2016","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.autrev.2022.103187_bb0095","doi-asserted-by":"crossref","first-page":"748e755","DOI":"10.1136\/jnnp-2012-303807","article-title":"Paediatric autoimmune encephalopathies: clinical features, laboratory investigations and outcomes in patients with or without antibodies to known central nervous system autoantigens","volume":"84","author":"Hacohen","year":"2013","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.autrev.2022.103187_bb0100","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/ana.24083","article-title":"Herpes simplex virus encephalitis is a trigger of brain autoimmunity","volume":"75","author":"Armangue","year":"2014","journal-title":"Ann Neurol"},{"key":"10.1016\/j.autrev.2022.103187_bb0105","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1212\/WNL.0000000000001072","article-title":"VZV brainstem encephalitis triggers NMDA receptor immunoreaction","volume":"83","author":"Schabitz","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2022.103187_bb0110","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1159\/000453545","article-title":"Anti-N-methyl-D-aspartate receptor encephalitis in HIV infection","volume":"8","author":"Patarata","year":"2016","journal-title":"Case Rep Neurol"},{"key":"10.1016\/j.autrev.2022.103187_bb0115","article-title":"Anti-N-methyl-D-aspartate receptor encephalitis associated with acute toxoplasma gondii infection: a case report","volume":"97","author":"Cai","year":"2018","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.autrev.2022.103187_bb0120","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000392","article-title":"Postmalaria neurologic syndrome associated with neurexin-3\u03b1 antibodies","volume":"4","author":"Costa","year":"2017","journal-title":"Neurol Neuroimmunol Neuroinflamm."},{"key":"10.1016\/j.autrev.2022.103187_bb0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11908-017-0556-y","article-title":"NMDAR encephalitis following herpes simplex virus encephalitis","volume":"19","author":"Galli","year":"2017","journal-title":"Curr Infect Dis Rep"},{"key":"10.1016\/j.autrev.2022.103187_bb0130","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1212\/WNL.0000000000003713","article-title":"Investigations in GABAA receptor antibody-associated encephalitis","volume":"88","author":"Spatola","year":"2017","journal-title":"Neurology."},{"issue":"11","key":"10.1016\/j.autrev.2022.103187_bb0135","article-title":"Postherpes simplex encephalitis: a case series of viral-triggered autoimmunity, synaptic autoantibodies and response to therapy","volume":"23","author":"Alexopoulos","year":"2018","journal-title":"Ther Adv Neurol Disord"},{"key":"10.1016\/j.autrev.2022.103187_bb0140","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/s12883-022-02637-x","article-title":"Caspr2 antibodies in herpes simplex encephalitis: an extension of the spectrum of virus induced autoimmunity? - a case report","volume":"22","author":"Berek","year":"2022","journal-title":"BMC Neurol"},{"key":"10.1016\/j.autrev.2022.103187_bb0145","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1212\/WNL.0000000000002125","article-title":"Autoimmune post-herpes simplex encephalitis of adults and teenagers","volume":"85","author":"Armangue","year":"2015","journal-title":"Neurology."},{"key":"10.1016\/j.autrev.2022.103187_bb0150","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.autrev.2012.03.001","article-title":"Anti-NMDA receptor encephalitis. The disorder, the diagnosis and the immunobiology","volume":"11","author":"Peery","year":"2012","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2022.103187_bb0155","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.3389\/fimmu.2019.02066","article-title":"Innate immunity in the central nervous system: a missing piece of the autoimmune encephalitis puzzle?","volume":"10","author":"Wesselingh","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2022.103187_bb0160","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1006\/jaut.2000.0490","article-title":"Molecular mimicry in campylobacter jejuni and helicobacter pylori lipopolysaccharides: contribution of gastrointestinal infections to autoimmunity","volume":"16","author":"Moran","year":"2001","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2022.103187_bb0165","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000458","article-title":"Anti-NMDA receptor encephalitis and nonencephalitic HSV-1 infection","volume":"5","author":"Salovin","year":"2018","journal-title":"Neurol Neuroimmunol Neuroinflamm."},{"key":"10.1016\/j.autrev.2022.103187_bb0170","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1093\/brain\/awy109","article-title":"Distinct HLA associations of LGI1 and CASPR2-antibody diseases","volume":"141","author":"Binks","year":"2018","journal-title":"Brain."},{"key":"10.1016\/j.autrev.2022.103187_bb0175","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000001140","article-title":"Human leukocyte antigen association study reveals DRB1*04:02 effects additional to DRB1*07:01 in anti-LGI1 encephalitis","volume":"9","author":"Peris Sempere","year":"2022","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10.1016\/j.autrev.2022.103187_bb0180","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1002\/ana.25216","article-title":"Genetic predisposition in anti-LGI1 and anti-NMDA receptor encephalitis","volume":"83","author":"Mueller","year":"2018","journal-title":"Ann Neurol"},{"key":"10.1016\/j.autrev.2022.103187_bb0185","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1136\/jnnp-2018-319714","article-title":"HLA class II allele DRB1*16:02 is associated with anti-NMDAR encephalitis","volume":"90","author":"Shu","year":"2019","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.autrev.2022.103187_bb0190","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1136\/jnnp-2018-319714","article-title":"HLA class II allele DRB1*16:02 is associated with anti-NMDAR encephalitis","volume":"90","author":"Shu","year":"2019","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.autrev.2022.103187_bb0195","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1111\/dmcn.13448","article-title":"Herpes simplex virus-induced anti-N-methyl-d-aspartate receptor encephalitis: a systematic literature review with analysis of 43 cases","volume":"59","author":"Nosadini","year":"2017","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.autrev.2022.103187_bb0200","doi-asserted-by":"crossref","first-page":"373","DOI":"10.3988\/jcn.2022.18.4.373","article-title":"Autoantibody encephalitis: presentation, diagnosis, and management","volume":"18","author":"Lancaster","year":"2022","journal-title":"J Clin Neurol"},{"key":"10.1016\/j.autrev.2022.103187_bb0205","doi-asserted-by":"crossref","first-page":"102348","DOI":"10.1016\/j.autrev.2019.102348","article-title":"Autoimmunity in psychotic disorders. Where we stand, challenges and opportunities","volume":"18","author":"Man\u00e9-Damas","year":"2019","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2022.103187_bb0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2022.103145","article-title":"Psychiatric manifestations of autoimmune encephalitis","volume":"21","author":"Ford","year":"2022","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2022.103187_bb0215","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S1474-4422(12)70310-1","article-title":"Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study","volume":"12","author":"Titulaer","year":"2013","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.autrev.2022.103187_bb0220","doi-asserted-by":"crossref","first-page":"906","DOI":"10.3389\/fneur.2019.00906","article-title":"Pediatric autoimmune encephalitis: case series from two Chinese tertiary pediatric neurology centers","volume":"10","author":"Zhang","year":"2019","journal-title":"Front Neurol"},{"key":"10.1016\/j.autrev.2022.103187_bb0225","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000130","article-title":"Earlier treatment of NMDAR antibody encephalitis in children results in a better outcome","volume":"2","author":"Byrne","year":"2015","journal-title":"Neurology-Neuroimmunol Neuroinflam"},{"key":"10.1016\/j.autrev.2022.103187_bb0230","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S1474-4422(12)70310-1","article-title":"Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study","volume":"12","author":"Titulaer","year":"2013","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.autrev.2022.103187_bb0235","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.pediatrneurol.2021.04.001","article-title":"Pediatric autoimmune encephalitis and its relationship with infection","volume":"120","author":"Li","year":"2021","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.autrev.2022.103187_bb0240","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.autrev.2017.12.009","article-title":"From HSV infection to erythema multiforme through autoimmune crossreactivity","volume":"17","author":"Lucchese","year":"2018","journal-title":"Autoimmun Rev"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997222001574?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997222001574?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T21:26:44Z","timestamp":1761600404000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997222001574"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":48,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["S1568997222001574"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2022.103187","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Autoimmune encephalitis after herpes simplex encephalitis: A still undefined condition","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2022.103187","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"103187"}}